Skip to main content

Progeny 3, Inc.

SEC CIK
0001536006
Latest filing
Aug 14, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Progeny 3, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2025
Holdings of CRNX by Progeny 3, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−24,000−100.0%Sold outHolders
Q1 202624,000$871.7K<0.1%00.0%UnchangedHolders
Q4 202524,000$1.12M0.1%+24,000NewHolders